Although we cannot, at this stage, exclude a potential impact of cancer types on LCN2 levels, the evaluation of human cancer patients using samples from the VCB biobank samples showed no significant differences in LCN2 levels between overall colorectal and pancreatic patients (Figure 5B). Here, LCN2 is linked to cancer.